混合技術を検証する追跡調査
上腕骨近位骨内血管アクセス挿入部位を特定するための混合技術を検証する追跡調査
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Texas
-
Spring Branch、Texas、アメリカ、78070
- Bulverde-Spring Branch EMS
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
説明
包含基準:
- 現在免許/認定されている救急医療技術者、救急救命士、または看護師 上腕骨近位 IO 挿入部位の使用に関する正式なトレーニングを受けていない トレーニング部分でデバイスと技術の適切な使用法をデモンストレーションし、デバイス トレーナーから参加の承認を得ている
除外基準:
- 上腕骨近位骨内血管アクセスの確立に関する以前のトレーニング
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:非ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
他の:Blended Technique for Intraosseous Insertion
Clinician device operators will be trained on the Blended Technique site identification method and perform one unilateral proximal humerus (PH) intraosseous needle insertion.
The blended technique is: The arm is positioned with the elbow adducted and shoulder internally rotated with the hand over the abdomen.
The operator places one hand in the axilla and the other hand along the midline of the upper arm laterally, to define the anterior and posterior borders.
The vertical plane of insertion lies in the middle of these borders.
Along the vertical axis, deeply palpate the PH until the junction of the surgical neck and humeral head is identified.
The insertion site is the greater tubercle, about 1-2 cm superior to the surgical neck.
Secondary confirmation is made by palpating the inter-tubercular groove with a 90º rotation of the arm, confirming the insertion site is lateral to the groove, and returning the arm back to a medially rotated position with the hand over the abdomen
|
Intraossesous Vascular Access in the proximal humerus
他の名前:
|
|
他の:Healthy Subjects: Blended Technique
Healthy subjects will receive bilateral intraosseous vascular access established in the proximal humerus performed by device operators using the blended technique.
|
Intraossesous Vascular Access in the proximal humerus
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Proximal Humerus Intraosseous (IO) Insertion Site Placement Total Score
時間枠:Day 1 Within 10 minutes following procedure
|
X-ray images of the inserted IO needle will be used to evaluate placement success and scored. Each insertion is scored by a musculoskeletal radiologist for two measures: Insertion Site Accuracy (scale range 0 - 3) and Needle Tip Location (scale range -7 to 7) as described below. The Total score is the sum of Insertion Site Accuracy Score and Needle Tip Location Score. Scale range -7 to 10; higher score indicates greater accuracy. Insertion Site Accuracy Score Scale is 0 to 3 where higher scores indicate greater accuracy: 3=center of greater tubercle, 2=perimeter of greater tubercle, 1=junction of greater tubercle and shaft or head, and 0=outside the greater tubercle. Needle tip Location Score Scale ranges from -7 to 7 where higher scores indicate more favorable needle tip location: 7=within center of proximal humerus (PH), 5=within PH not centered, 3= Near miss of PH, -3=In humeral head, -3=on epiphyseal line, -5=lateral miss (of the humerus), -7=medial miss (of the humerus). |
Day 1 Within 10 minutes following procedure
|
|
Time to Intraosseous Catheter Placement
時間枠:1 day, within 10 minutes of procedure
|
The amount of time it takes for the device operator to identify the proximal humerus intraosseous (IO) insertion site using their assigned proximal humerus IO site identification method and insert the IO needle.
Timing starts from the time the participant begins to palpate the proximal humerus and stops when the IO needle is inserted.
|
1 day, within 10 minutes of procedure
|
|
Level of Confidence Score Pre-intraosseous Insertion
時間枠:Day 1 within 10 minutes of completing training
|
Device operators scored their perceived Level of Confidence with their assigned Intraosseous (IO) Insertion method.
The score was reported following the completion of training but before performing the unilateral IO insertion.
The Level of Confidence scale scores range from 1 to 5, where.
1=not at all confident, 2=slightly confident, 3=moderately confident, 4=very confident, and 5=extremely confident.
Higher scores indicate greater level of confidence.
|
Day 1 within 10 minutes of completing training
|
|
Level of Confidence Score Post-intraosseous Insertion
時間枠:Day 1 within 10 minutes of completing the unilateral intraosseous insertion
|
Device operators scored their perceived Level of Confidence with their assigned Intraosseous (IO) Insertion method for their one unilateral proximal humerus IO site procedure.
The score was reported after performing the unilateral IO insertion.
The Level of Confidence scale scores range from 1 to 5, where.
1=not at all confident, 2=slightly confident, 3=moderately confident, 4=very confident, and 5=extremely confident.
Higher scores indicate greater level of confidence.
|
Day 1 within 10 minutes of completing the unilateral intraosseous insertion
|
|
Ease of Use Score Pre-intraosseous Insertion
時間枠:Day 1 within 10 minutes of completing the unilateral intraosseous insertion
|
Device operators will score their perceived Ease of Use for their assigned Intraosseous Insertion method for their one unilateral proximal humerus IO site procedure.
The score was reported following the completion of training but before performing the unilateral IO insertion.
The Ease of Use scale scores range from 1 to 5, where 1=very difficult, 2=difficult, 3=neutral, 4=easy, and 5=very easy.
Higher scores indicate greater ease of use.
|
Day 1 within 10 minutes of completing the unilateral intraosseous insertion
|
|
Ease of Use Score Post-intraosseous Insertion
時間枠:Day 1 within 10 minutes of completing the unilateral insertion
|
Device operators will score their perceived Ease of Use for their assigned Intraosseous Insertion method for their one unilateral proximal humerus IO site procedure.
The score was reported after completing the unilateral intraosseous insertion.
The Ease of Use scale scores range from 1 to 5, where 1=very difficult, 2=difficult, 3=neutral, 4=easy, and 5=very easy.
Higher scores indicate greater ease of use.
|
Day 1 within 10 minutes of completing the unilateral insertion
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Intraosseous Infusion Flow Rates
時間枠:Day 1 after establishing IO vascular access
|
Intraosseous infusion flow rates attained at tested infusion pressures, which may include Gravity; 100 mmHg, 200 mmHg and 300 mmHg.
|
Day 1 after establishing IO vascular access
|
|
Time in Seconds for Fluid Delivery From the Proximal Humerus to the Heart
時間枠:Day 1 after IO insertion
|
Time in seconds for fluid delivery from the proximal humerus to the heart, using visualization of contrast injection under fluoroscopy was performed and measured once for the participants in the Healthy Subjects: Blended Technique arm.
|
Day 1 after IO insertion
|
|
Success Rate of Obtaining Laboratory Results for Both Intraosseous and Peripheral Venous Specimens
時間枠:Day 1 within 30 minutes after establishing proximal humerus IO vascular access and peripheral venous access
|
Number of Participants with Laboratory Results Successfully Obtained from both intraosseous (IO) and peripheral venous blood specimens.
Success was determined if the point-of-care laboratory analysis system provided laboratory results values for both IO and Peripheral Venous specimens.
It was deemed unsuccessful if the point-of-care system provided no laboratory results values and/or noted an error for at least one specimen.
An intraosseous blood specimen and a peripheral venous blood specimen were collected from each subject
|
Day 1 within 30 minutes after establishing proximal humerus IO vascular access and peripheral venous access
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Larry J Miller, MD、Vidacare Corporation
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (推定)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 2013-06 (AP HM)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。